Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C

被引：4
|
作者：
Poynard, T [1 ]
机构：
[1] Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, F-75651 Paris, France
来源：
GUT | 2003年 / 52卷 / 10期
关键词：
D O I：
10.1136/gut.52.10.1532
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1532 / 1532
页数：1
相关论文
共 50 条
  • [1] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [2] Triple combination of pegylated interferon alpha 2b, ribavirin and amantadine for treatment of chronic hepatitis
    Younossi, ZM
    McCullough, AJ
    Barnes, DS
    Post, A
    Ong, JP
    Mullen, KD
    Carey, WD
    O'Shea, R
    Levinthal, G
    Gramlich, T
    Martin, LM
    Bringman, D
    Tavill, A
    Ferguson, R
    GASTROENTEROLOGY, 2003, 124 (04) : A781 - A781
  • [3] Pegylated interferon α-2b, ribavirin and amantadine for chronic hepatitis C
    Younossi, ZM
    McCullough, A
    Barnes, D
    Post, A
    Ong, J
    O'Shea, R
    Martin, LM
    Bringman, D
    Farmer, D
    Levinthal, G
    Mullen, KD
    Carey, WD
    Tavill, AS
    Ferguson, R
    Gramlich, T
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (05) : 970 - 975
  • [4] Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C
    Zobair M. Younossi
    Arthur C. McCullough
    David S. Barnes
    Anthony Post
    Janus P. Ong
    Robert O’shea
    Lisa M. Martin
    Diane Bringman
    Denise Farmer
    Gavin Levinthal
    Kevin D. Mullen
    William D. Carey
    Anthony S. Tavill
    Roy Ferguson
    Terry Gramlich
    Digestive Diseases and Sciences, 2005, 50 : 970 - 975
  • [5] Cost effectiveness of interferon α2b combined with ribavirin for the treatment of chronic hepatitis C
    Younossi, ZM
    Singer, ME
    McHutchison, JG
    Shermock, KM
    HEPATOLOGY, 1999, 30 (05) : 1318 - 1324
  • [6] Response to pegylated interferon α-2b and ribavirin in children with chronic hepatitis C
    Baker, Robert D.
    Dee, Deborah
    Baker, Susan S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (01) : 111 - 114
  • [7] Cost-effectiveness of combination peginterferon α-2a and ribavirin compared with interferon α-2b and ribavirin in patients with chronic hepatitis C
    Sullivan, SD
    Jensen, M
    Bernstein, DE
    Hassanein, TI
    Foster, GR
    Lee, SS
    Cheinquer, H
    Craxi, A
    Cooksley, G
    Klaskala, W
    Pettit, K
    Patel, KK
    Green, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (08): : 1490 - 1496
  • [8] Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatitis C in HIV patients
    Cargnel, A
    Angeli, E
    Mainini, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, P
    GASTROENTEROLOGY, 2003, 124 (04) : A766 - A766
  • [9] Cost-effectiveness analysis of interferon α-2b with ribavirin for chronic hepatitis C infection
    Malone, DC
    FORMULARY, 2000, 35 (08) : 681 - +
  • [10] Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C
    Kim, WR
    Poterucha, JJ
    Gross, JB
    HEPATOLOGY, 2000, 31 (03) : 807 - 807
12345